Only patients who received rituximab, ipilimumab plus nivolumab, and trastuzumab plus pertuzumab had infusion-related reactions in the real-world cohort.

In the phase 2 EXTEND trial, investigators randomly assigned patients with oligometastatic prostate cancer to ADT or MDT + ADT, with further stratification by intermittent vs continuous ADT that was ...

Researchers sought to determine whether adding nivolumab to AVD would be an effective treatment for older patients with classic HL.

Our findings continue to highlight the complex landscape of cancer care costs and call for further research and policy changes,” the researchers wrote.

Researchers sought to determine whether VRD induction would be effective and tolerable for transplant-eligible patients with NDMM.

HealthDay News — Rural residents with colon cancer are significantly less likely to undergo minimally invasive surgery (MIS) and significantly more likely to experience worse outcomes compared with ...

Researchers investigated the association between lifestyle changes after screening for colonoscopy and the development of ...

HealthDay News — For patients treated with nicotinamide, the risk for skin cancer is reduced, especially when initiated after ...

Most adverse events in the combination group were attributed to lenvatinib and could be managed by dose reduction or symptomatic treatment.

Given the potential for volatility in future cancer research and global health funding from the USA due to federal funding cuts, there might be increased strategic value in other countries ...

Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI.

Researchers examined potential differences in the risk factor profiles of nevus-associated vs de novo melanoma.